Marginal note:Additions to Schedule G
21.91 (1) For the purpose of preventing injury to health or preventing a person from being deceived or misled, the Minister may, by order, add a description of a therapeutic product or a class of therapeutic products to Schedule G if the Minister believes that the therapeutic product or products represent an emerging or innovative technological, scientific or medical development.
Marginal note:Factors
(2) Before adding a description of a therapeutic product or a class of therapeutic products to Schedule G, the Minister shall consider the following factors:
(a) the degree of uncertainty respecting the risks and benefits associated with the therapeutic product or products and the measures that are available to adequately manage and control those risks;
(b) the extent to which the therapeutic product or products are different from therapeutic products for which therapeutic product authorizations have been issued under the regulations;
(c) the extent to which existing legal frameworks are adequate to prevent injury to health or to prevent persons from being deceived or misled; and
(d) the prescribed factors, if any.
Marginal note:Deletion from Schedule G
(3) The Minister may, by order, delete the description of a therapeutic product or a class of therapeutic products from Schedule G.
- 2019, c. 29, s. 169
Version in force since June 21, 2019